BioSpace News Archive

Evonik , a global leader in biomaterials, is expanding its RESOMER portfolio of bioresorbable polymers for controlled-release parenteral drug formulations.

Mr. Phillips will focus on further advancing Biohaven’s infrastructure to support the Company’s accounting, external reporting and finance capabilities.

Experienced life sciences executive with strong history of successful advancement of novel drug platforms and pipeline development [13-November-2017] OXFORD, England, November 13, 2017 /PRNewswire/ -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, is pleased to announce the appointment of Dr Antonin &quo

The CAB will provide counsel to the company as OMEICOS starts to design a Phase II program for maintenance of sinus rhythm in patients with atrial fibrillation.

Bruker today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

In a letter dated November 10, 2017, the Exchange notified the Company that it had successfully regained compliance with the NYSE American continued listing standards.

The latest data updates the progression results at 19 weeks for all 20 patients.

ARUP Labs and ASI announced today they have completed a multi-year collaboration, leading to the launch of ASI’s PathFusion.

The NBT system uses a unique method of TMS known as navigated Transcranial Magnetic Stimulation.

Cmed, today announced that it will showcase its encapsia clinical data suite at two leading oncology meetings, Clinical Operations in Oncology Trials Europe, taking place 5-6 December in Munich, Germany, and the ASH Annual Meeting, taking place 9-12 December in Atlanta, GA.